organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

4-[(4-Bromo­phenyl)amino]-2-methyl­­idene-4-oxo­butanoic acid

aDepartment of Studies in Chemistry, Mangalore University, Mangalagangotri 574 199, India, bDepartment of Studies in Chemistry, Industrial Chemistry Section, Mangalore University, Mangalagangotri 574 199, India, and cDepartment of Chemistry, Keene State College, 229 Main Street, Keene, NH 03435-2001, USA
*Correspondence e-mail: jjasinski@keene.edu

(Received 28 May 2014; accepted 3 June 2014; online 14 June 2014)

In the title compound, C11H10BrNO3, two independent mol­ecules (A and B) crystallize in the asymmetric unit. The dihedral angles between the mean planes of the 4-bromo­phenyl ring and amide group are 24.8 (7) in mol­ecule A and 77.1 (6)° in mol­ecule B. The mean plane of the methyl­idene group is further inclined by 75.6 (4) in mol­ecule A and 72.5 (6)° in mol­ecule B from that of the amide group. In the crystal, N—H⋯O hydrogen bonds formed by amide groups and O—H⋯O hydrogen bonds formed by carb­oxy­lic acid groups are observed and supported additionally by weak C—H⋯O inter­actions between the methyl­idene and amide groups. Together, these link the mol­ecules into chains of dimers along [110] and form R22(8) graph-set motifs.

Related literature

For the pharmacological activity of amide derivatives, see: Galanakis et al. (2004[Galanakis, D., Kourounakis, A. P., Tsiakitzis, K. C., Doulgkeris, C., Rekka, E. A., Gavalas, A., Kravaritou, C., Christos, C. & Kourounakis, P. N. (2004). Bioorg. Med. Chem. Lett. 14, 3639-3643.]); Kumar & Knaus (1993[Kumar, P. & Knaus, E. E. (1993). Eur. J. Med. Chem. 28, 881-885.]); Ban et al. (1998[Ban, M., Taguchi, H., Katushima, T., Takahashi, M., Shinoda, K., Watanabe, A. & Tominaga, T. (1998). Bioorg. Med. Chem. 6, 1069-1076.]); Ukrainets et al. (2006[Ukrainets, I. V., Sidorenko, L. V., Petrushovo, L. A. & Gorokhova, O. V. (2006). Chem. Heterocycl. Comput. 42, 64-69.]), Lesyk & Zimenkovsky (2004[Lesyk, R. & Zimenkovsky, B. (2004). Curr. Org. Chem. 8, 1547-1578.]); Gududuru et al. (2004[Gududuru, V., Hurh, E., Dalton, J. T. & Miller, D. D. (2004). Bioorg. Med. Chem. Lett. 14, 5289-5293.]). For related structures, see: Nayak et al. (2013a[Nayak, P. S., Narayana, B., Yathirajan, H. S., Gerber, T., Brecht, B. van & Betz, R. (2013a). Acta Cryst. E69, o83.],b[Nayak, P. S., Narayana, B., Jasinski, J. P., Yathirajan, H. S. & Kaur, M. (2013b). Acta Cryst. E69, o1752.]). For standard bond lengths, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]).

[Scheme 1]

Experimental

Crystal data
  • C11H10BrNO3

  • Mr = 284.11

  • Triclinic, [P \overline 1]

  • a = 6.2782 (4) Å

  • b = 8.3251 (5) Å

  • c = 21.3244 (12) Å

  • α = 96.462 (5)°

  • β = 92.026 (5)°

  • γ = 95.390 (5)°

  • V = 1101.38 (11) Å3

  • Z = 4

  • Cu Kα radiation

  • μ = 5.04 mm−1

  • T = 173 K

  • 0.44 × 0.28 × 0.14 mm

Data collection
  • Agilent Eos Gemini diffractometer

  • Absorption correction: multi-scan (CrysAlis PRO and CrysAlis RED; Agilent, 2012[Agilent (2012). CrysAlis PRO and CrysAlis RED. Agilent Technologies, Yarnton, England.]) Tmin = 0.162, Tmax = 1.000

  • 7163 measured reflections

  • 4131 independent reflections

  • 3490 reflections with I > 2σ(I)

  • Rint = 0.033

Refinement
  • R[F2 > 2σ(F2)] = 0.076

  • wR(F2) = 0.227

  • S = 1.03

  • 4131 reflections

  • 291 parameters

  • H-atom parameters constrained

  • Δρmax = 2.73 e Å−3

  • Δρmin = −0.79 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
O3A—H3A⋯O2Bi 0.84 1.85 2.685 (5) 174
N1A—H1A⋯O1Bii 0.88 2.06 2.933 (5) 170
O3B—H3B⋯O2Aiii 0.84 1.82 2.654 (5) 170
N1B—H1B⋯O1Aiv 0.88 2.04 2.848 (6) 152
C5B—H5BB⋯O1Av 0.95 2.54 3.464 (7) 164
Symmetry codes: (i) x, y, z-1; (ii) -x+1, -y+1, -z+1; (iii) x, y, z+1; (iv) -x+2, -y+2, -z+1; (v) -x+1, -y+2, -z+1.

Data collection: CrysAlis PRO (Agilent, 2012[Agilent (2012). CrysAlis PRO and CrysAlis RED. Agilent Technologies, Yarnton, England.]); cell refinement: CrysAlis PRO; data reduction: CrysAlis RED (Agilent, 2012[Agilent (2012). CrysAlis PRO and CrysAlis RED. Agilent Technologies, Yarnton, England.]); program(s) used to solve structure: SUPERFLIP (Palatinus et al., 2012[Palatinus, L., Prathapa, S. J. & van Smaalen, S. (2012). J. Appl. Cryst. 45, 575-580.]); program(s) used to refine structure: SHELXL2012 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: OLEX2 (Dolomanov et al., 2009[Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339-341.]); software used to prepare material for publication: OLEX2.

Supporting information


Comment top

Amide bonds play a major role in the elaboration and composition of biological systems, which are the main chemical bonds that link amino acid building blocks together to give proteins. Amide bonds are not limited to biological systems and are indeed present in a huge array of molecules, including major marketed drugs. Amide derivatives possessing anti-inflammatory (Galanakis et al., 2004; Kumar et al., 1993; Ban et al., 1998), antimicrobial (Ukrainets et al., 2006), anti-tubercular (Lesyk et al., 2004) and antiproliferative (Gududuru et al., 2004) activities are reported in the literature. Crystal structures of some related amide derivatives include, viz., 4-(4-iodoanilino)-2-methylene-4-oxobutanoic acid and 4-(3-fluoro-4-methylanilino)-2-methylidene-4-oxobutanoic acid (Nayak et al., 2013a,b). Hence in view of its pharmacological importance, the title compound 4-[(4-bromophenyl)amino]-2-methylidene-4-oxobutanoic acid (I), C11H10BrNO3, was synthesized from 3-methylidenedihydrofuran-2,5-dione with good yields and its crystal structure is reported here.

In the title compound, two independent molecules (A & B) crystallize in the asymmetric unit (Fig. 1). The N–C(=O) bond lengths of 1.359 (6)A (A) and 1.346 (6)Å (B) are indicative of amide-type resonance. The bond lengths of the remaining atoms are in normal ranges (Allen et al., 1987). In the crystal, classical N—H···O and O—H···O hydrogen bonds are observed supported additionally by weak C—H···O intermolecular interactions between the 2-methylidene and amide groups (Table 1, Fig. 2) linking the molecules into chains of dimers along [1 1 0]. The N—H···O hydrogen bonds are supported by the carbonyl oxygen atom of the amide functionality as the acceptor. The carboxylic acid groups form a dimeric hydrogen bonding pattern commonly seen for many carbolylic acids into R22(8) graph-set motifs (Fig. 3). The dihedral angles between the mean planes of the 4-bromophenyl ring (C6A–C11A or C6B–C11B) and oxoamine group (N1A/C1A/O1A/C2A or N1B/C1B/O1B/C2B) are 24.8 (7)° (A) and 77.1 (6)° (B), respectively. The mean plane of the 2-methylidene group (C2A–C5A or C2B–C5B) is further inclined by 75.6 (4)° (A) and 72.5 (6)° (B) from that of the oxoamine group (N1A/C1A/O1A/C2A or N1B/C1B/O1B/C2B).

Related literature top

For the pharmacological activity of amide derivatives, see: Galanakis et al. (2004); Kumar & Knaus (1993); Ban et al. (1998); Ukrainets et al. (2006), Lesyk & Zimenkovsky (2004); Gududuru et al. (2004). For related structures, see: Nayak et al. (2013a,b). For standard bond lengths, see: Allen et al. (1987).

Experimental top

3-Methylidenedihydrofuran-2,5-dione (0.112 g, 1 mmol) was dissolved in 30 ml acetone and stirred at ambient temperature. 4-Bromoaniline (0.172 g, 1 mmol) in 20 mL acetone was added over 30 mins (Fig. 4). After sirring for 1.5 h the slurry was filtered. The solid was washed with acetone and dried to give title compound, C11H10BrNO3. Single crystals were grown from methanol by the slow evaporation method (yield 0.248 g, 87.32%; m.p.: 441–443 K).

Refinement top

All of the H atoms were placed in their calculated positions and then refined using the riding model with Atom—H lengths of 0.95Å (CH), 0.99Å (CH2), 0.88Å (NH) or 0.84Å (OH). Isotropic displacement parameters for these atoms were set to 1.2 (CH, CH2, NH) or 1.5 (OH) times Ueq of the parent atom. The idealised tetrahedral OH was refined as a rotating group: O3A(H3A), O3B(H3B). The highest four peaks in the residual density map are at approximately 1Å from the bromine atoms and have a height of about 2 e-3.

Structure description top

Amide bonds play a major role in the elaboration and composition of biological systems, which are the main chemical bonds that link amino acid building blocks together to give proteins. Amide bonds are not limited to biological systems and are indeed present in a huge array of molecules, including major marketed drugs. Amide derivatives possessing anti-inflammatory (Galanakis et al., 2004; Kumar et al., 1993; Ban et al., 1998), antimicrobial (Ukrainets et al., 2006), anti-tubercular (Lesyk et al., 2004) and antiproliferative (Gududuru et al., 2004) activities are reported in the literature. Crystal structures of some related amide derivatives include, viz., 4-(4-iodoanilino)-2-methylene-4-oxobutanoic acid and 4-(3-fluoro-4-methylanilino)-2-methylidene-4-oxobutanoic acid (Nayak et al., 2013a,b). Hence in view of its pharmacological importance, the title compound 4-[(4-bromophenyl)amino]-2-methylidene-4-oxobutanoic acid (I), C11H10BrNO3, was synthesized from 3-methylidenedihydrofuran-2,5-dione with good yields and its crystal structure is reported here.

In the title compound, two independent molecules (A & B) crystallize in the asymmetric unit (Fig. 1). The N–C(=O) bond lengths of 1.359 (6)A (A) and 1.346 (6)Å (B) are indicative of amide-type resonance. The bond lengths of the remaining atoms are in normal ranges (Allen et al., 1987). In the crystal, classical N—H···O and O—H···O hydrogen bonds are observed supported additionally by weak C—H···O intermolecular interactions between the 2-methylidene and amide groups (Table 1, Fig. 2) linking the molecules into chains of dimers along [1 1 0]. The N—H···O hydrogen bonds are supported by the carbonyl oxygen atom of the amide functionality as the acceptor. The carboxylic acid groups form a dimeric hydrogen bonding pattern commonly seen for many carbolylic acids into R22(8) graph-set motifs (Fig. 3). The dihedral angles between the mean planes of the 4-bromophenyl ring (C6A–C11A or C6B–C11B) and oxoamine group (N1A/C1A/O1A/C2A or N1B/C1B/O1B/C2B) are 24.8 (7)° (A) and 77.1 (6)° (B), respectively. The mean plane of the 2-methylidene group (C2A–C5A or C2B–C5B) is further inclined by 75.6 (4)° (A) and 72.5 (6)° (B) from that of the oxoamine group (N1A/C1A/O1A/C2A or N1B/C1B/O1B/C2B).

For the pharmacological activity of amide derivatives, see: Galanakis et al. (2004); Kumar & Knaus (1993); Ban et al. (1998); Ukrainets et al. (2006), Lesyk & Zimenkovsky (2004); Gududuru et al. (2004). For related structures, see: Nayak et al. (2013a,b). For standard bond lengths, see: Allen et al. (1987).

Computing details top

Data collection: CrysAlis PRO (Agilent, 2012); cell refinement: CrysAlis PRO (Agilent, 2012); data reduction: CrysAlis RED (Agilent, 2012); program(s) used to solve structure: SUPERFLIP (Palatinus et al., 2012); program(s) used to refine structure: SHELXL2012 (Sheldrick, 2008); molecular graphics: OLEX2 (Dolomanov et al., 2009); software used to prepare material for publication: OLEX2 (Dolomanov et al., 2009).

Figures top
[Figure 1] Fig. 1. ORTEP drawing of the title compound, C11H10BrNO3, showing the labeling scheme with 30% probability displacement ellipsoids.
[Figure 2] Fig. 2. Molecular packing for the title compound viewed along the a axis. Dashed lines indicate N—H···O, O—H···O hydrogen bonds and weak C—H···O intermolecular interactions linking the molecules into chains of dimers along [1 1 0]. H atoms not involved in hydrogen bonding or weak intermolecular interactions have been removed for clarity.
[Figure 3] Fig. 3. Molecular packing for the title compound viewed along the b axis. Dashed lines indicate O—H···O hydrogen bonds between the carboxylic groups forming R22(8) graph-set motifs linking the molecules into chains of dimers along [1 1 0]. H atoms not involved in hydrogen bonding have been removed for clarity.
[Figure 4] Fig. 4. Synthesis of C11H10BrNO3.
4-[(4-Bromophenyl)amino]-2-methylidene-4-oxobutanoic acid top
Crystal data top
C11H10BrNO3V = 1101.38 (11) Å3
Mr = 284.11Z = 4
Triclinic, P1F(000) = 568
a = 6.2782 (4) ÅDx = 1.713 Mg m3
b = 8.3251 (5) ÅCu Kα radiation, λ = 1.54184 Å
c = 21.3244 (12) ŵ = 5.04 mm1
α = 96.462 (5)°T = 173 K
β = 92.026 (5)°Prism, colourless
γ = 95.390 (5)°0.44 × 0.28 × 0.14 mm
Data collection top
Agilent Eos Gemini
diffractometer
3490 reflections with I > 2σ(I)
Detector resolution: 16.0416 pixels mm-1Rint = 0.033
ω scansθmax = 71.3°, θmin = 4.2°
Absorption correction: multi-scan
(CrysAlis PRO and CrysAlis RED; Agilent, 2012)
h = 76
Tmin = 0.162, Tmax = 1.000k = 810
7163 measured reflectionsl = 2625
4131 independent reflections
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.076H-atom parameters constrained
wR(F2) = 0.227 w = 1/[σ2(Fo2) + (0.1446P)2 + 3.2341P]
where P = (Fo2 + 2Fc2)/3
S = 1.03(Δ/σ)max < 0.001
4131 reflectionsΔρmax = 2.73 e Å3
291 parametersΔρmin = 0.79 e Å3
0 restraints
Crystal data top
C11H10BrNO3γ = 95.390 (5)°
Mr = 284.11V = 1101.38 (11) Å3
Triclinic, P1Z = 4
a = 6.2782 (4) ÅCu Kα radiation
b = 8.3251 (5) ŵ = 5.04 mm1
c = 21.3244 (12) ÅT = 173 K
α = 96.462 (5)°0.44 × 0.28 × 0.14 mm
β = 92.026 (5)°
Data collection top
Agilent Eos Gemini
diffractometer
4131 independent reflections
Absorption correction: multi-scan
(CrysAlis PRO and CrysAlis RED; Agilent, 2012)
3490 reflections with I > 2σ(I)
Tmin = 0.162, Tmax = 1.000Rint = 0.033
7163 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0760 restraints
wR(F2) = 0.227H-atom parameters constrained
S = 1.03Δρmax = 2.73 e Å3
4131 reflectionsΔρmin = 0.79 e Å3
291 parameters
Special details top

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
Br1A0.19572 (14)0.90862 (10)0.46174 (4)0.0619 (3)
O1A0.8488 (6)0.7490 (4)0.20741 (18)0.0363 (9)
O2A0.6832 (6)0.6335 (5)0.05368 (18)0.0338 (8)
O3A1.0137 (6)0.7205 (5)0.02870 (19)0.0370 (9)
H3A0.94640.76070.00050.056*
N1A0.5872 (7)0.5635 (5)0.2341 (2)0.0275 (9)
H1A0.52460.46490.22290.033*
C1A0.7571 (7)0.6114 (6)0.2006 (2)0.0240 (9)
C2A0.8300 (8)0.4766 (6)0.1541 (2)0.0266 (10)
H2AA0.90360.40040.17770.032*
H2AB0.70330.41520.13070.032*
C3A0.9795 (8)0.5448 (6)0.1078 (2)0.0274 (10)
C4A0.8780 (8)0.6358 (6)0.0606 (2)0.0269 (10)
C5A1.1839 (9)0.5217 (7)0.1064 (3)0.0354 (11)
H5AA1.26920.56360.07490.042*
H5AB1.24610.46330.13700.042*
C6A0.5009 (8)0.6552 (6)0.2849 (2)0.0279 (10)
C7A0.6134 (10)0.7860 (7)0.3221 (3)0.0375 (12)
H7A0.75420.82300.31180.045*
C8A0.5228 (11)0.8617 (8)0.3733 (3)0.0448 (14)
H8A0.60060.95160.39810.054*
C9A0.3196 (10)0.8086 (7)0.3892 (3)0.0400 (13)
C10A0.2019 (9)0.6772 (8)0.3529 (3)0.0426 (13)
H10A0.06080.64150.36340.051*
C11A0.2942 (9)0.6008 (7)0.3017 (3)0.0392 (12)
H11A0.21720.50990.27740.047*
Br1B1.30729 (11)0.53869 (9)0.55597 (3)0.0518 (3)
O1B0.6584 (6)0.7564 (4)0.79041 (17)0.0313 (8)
O2B0.8098 (5)0.8720 (5)0.94320 (18)0.0333 (8)
O3B0.4808 (6)0.7820 (5)0.96889 (19)0.0365 (8)
H3B0.54990.72750.99190.055*
N1B0.8836 (7)0.9562 (5)0.7586 (2)0.0310 (9)
H1B0.92721.06060.76450.037*
C1B0.7305 (7)0.8992 (6)0.7954 (2)0.0237 (9)
C2B0.6529 (8)1.0295 (6)0.8428 (2)0.0276 (10)
H2BA0.77841.09390.86570.033*
H2BB0.57401.10400.81980.033*
C3B0.5089 (8)0.9580 (5)0.8900 (2)0.0252 (9)
C4B0.6144 (8)0.8670 (6)0.9365 (2)0.0258 (9)
C5B0.3032 (8)0.9786 (7)0.8930 (2)0.0331 (11)
H5BA0.22190.93510.92500.040*
H5BB0.23671.03680.86320.040*
C6B0.9792 (8)0.8566 (6)0.7107 (2)0.0297 (10)
C7B1.1837 (9)0.8118 (7)0.7222 (3)0.0334 (11)
H7B1.25670.84490.76200.040*
C8B1.2805 (8)0.7188 (7)0.6754 (3)0.0343 (11)
H8B1.42070.68890.68300.041*
C9B1.1733 (9)0.6699 (7)0.6181 (2)0.0336 (11)
C10B0.9703 (9)0.7144 (8)0.6061 (3)0.0424 (13)
H10B0.89770.68080.56630.051*
C11B0.8740 (8)0.8084 (7)0.6526 (3)0.0359 (12)
H11B0.73500.83980.64450.043*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
Br1A0.0789 (6)0.0637 (5)0.0493 (5)0.0310 (4)0.0312 (4)0.0047 (3)
O1A0.041 (2)0.0251 (18)0.040 (2)0.0048 (16)0.0117 (16)0.0027 (14)
O2A0.0245 (18)0.039 (2)0.040 (2)0.0063 (15)0.0030 (14)0.0113 (15)
O3A0.0278 (18)0.047 (2)0.039 (2)0.0037 (16)0.0037 (15)0.0125 (16)
N1A0.027 (2)0.0222 (19)0.032 (2)0.0017 (16)0.0045 (16)0.0020 (15)
C1A0.026 (2)0.020 (2)0.026 (2)0.0045 (18)0.0000 (17)0.0010 (17)
C2A0.029 (2)0.021 (2)0.030 (2)0.0065 (18)0.0011 (18)0.0014 (17)
C3A0.028 (2)0.021 (2)0.031 (2)0.0035 (18)0.0017 (19)0.0039 (18)
C4A0.026 (2)0.026 (2)0.027 (2)0.0023 (18)0.0053 (18)0.0024 (18)
C5A0.033 (3)0.040 (3)0.034 (3)0.011 (2)0.001 (2)0.003 (2)
C6A0.030 (2)0.024 (2)0.032 (2)0.0059 (19)0.0064 (19)0.0058 (18)
C7A0.044 (3)0.030 (3)0.038 (3)0.000 (2)0.007 (2)0.001 (2)
C8A0.055 (4)0.040 (3)0.038 (3)0.004 (3)0.007 (3)0.001 (2)
C9A0.047 (3)0.039 (3)0.039 (3)0.019 (3)0.021 (2)0.008 (2)
C10A0.030 (3)0.046 (3)0.054 (4)0.009 (2)0.016 (2)0.008 (3)
C11A0.030 (3)0.034 (3)0.054 (3)0.003 (2)0.011 (2)0.002 (2)
Br1B0.0503 (5)0.0635 (5)0.0428 (4)0.0220 (3)0.0143 (3)0.0059 (3)
O1B0.0333 (19)0.0234 (17)0.0361 (19)0.0004 (14)0.0089 (14)0.0006 (14)
O2B0.0243 (18)0.038 (2)0.039 (2)0.0041 (15)0.0041 (14)0.0113 (15)
O3B0.0252 (17)0.047 (2)0.040 (2)0.0045 (16)0.0022 (14)0.0143 (16)
N1B0.030 (2)0.024 (2)0.037 (2)0.0008 (17)0.0092 (17)0.0013 (16)
C1B0.020 (2)0.024 (2)0.027 (2)0.0057 (18)0.0015 (17)0.0004 (17)
C2B0.030 (2)0.022 (2)0.032 (2)0.0050 (19)0.0047 (19)0.0008 (18)
C3B0.026 (2)0.020 (2)0.029 (2)0.0034 (18)0.0031 (18)0.0034 (17)
C4B0.024 (2)0.025 (2)0.028 (2)0.0052 (18)0.0026 (17)0.0013 (17)
C5B0.031 (3)0.037 (3)0.031 (3)0.008 (2)0.002 (2)0.001 (2)
C6B0.028 (2)0.026 (2)0.036 (3)0.0035 (19)0.0087 (19)0.0030 (19)
C7B0.032 (3)0.035 (3)0.033 (3)0.004 (2)0.002 (2)0.002 (2)
C8B0.030 (3)0.041 (3)0.034 (3)0.013 (2)0.005 (2)0.004 (2)
C9B0.033 (3)0.036 (3)0.033 (3)0.008 (2)0.009 (2)0.000 (2)
C10B0.032 (3)0.060 (4)0.034 (3)0.009 (3)0.002 (2)0.001 (2)
C11B0.026 (2)0.046 (3)0.038 (3)0.011 (2)0.002 (2)0.006 (2)
Geometric parameters (Å, º) top
Br1A—C9A1.899 (5)Br1B—C9B1.893 (5)
O1A—C1A1.223 (6)O1B—C1B1.224 (6)
O2A—C4A1.225 (6)O2B—C4B1.226 (6)
O3A—H3A0.8400O3B—H3B0.8400
O3A—C4A1.312 (6)O3B—C4B1.311 (6)
N1A—H1A0.8800N1B—H1B0.8800
N1A—C1A1.359 (6)N1B—C1B1.346 (6)
N1A—C6A1.408 (6)N1B—C6B1.428 (6)
C1A—C2A1.527 (6)C1B—C2B1.525 (6)
C2A—H2AA0.9900C2B—H2BA0.9900
C2A—H2AB0.9900C2B—H2BB0.9900
C2A—C3A1.506 (7)C2B—C3B1.511 (7)
C3A—C4A1.487 (7)C3B—C4B1.488 (7)
C3A—C5A1.316 (7)C3B—C5B1.321 (7)
C5A—H5AA0.9500C5B—H5BA0.9500
C5A—H5AB0.9500C5B—H5BB0.9500
C6A—C7A1.391 (7)C6B—C7B1.392 (7)
C6A—C11A1.406 (7)C6B—C11B1.382 (8)
C7A—H7A0.9500C7B—H7B0.9500
C7A—C8A1.367 (8)C7B—C8B1.385 (8)
C8A—H8A0.9500C8B—H8B0.9500
C8A—C9A1.377 (9)C8B—C9B1.375 (8)
C9A—C10A1.400 (9)C9B—C10B1.383 (8)
C10A—H10A0.9500C10B—H10B0.9500
C10A—C11A1.374 (8)C10B—C11B1.384 (8)
C11A—H11A0.9500C11B—H11B0.9500
C4A—O3A—H3A109.5C4B—O3B—H3B109.5
C1A—N1A—H1A116.6C1B—N1B—H1B118.2
C1A—N1A—C6A126.8 (4)C1B—N1B—C6B123.7 (4)
C6A—N1A—H1A116.6C6B—N1B—H1B118.2
O1A—C1A—N1A123.8 (4)O1B—C1B—N1B123.0 (4)
O1A—C1A—C2A122.0 (4)O1B—C1B—C2B123.2 (4)
N1A—C1A—C2A114.1 (4)N1B—C1B—C2B113.8 (4)
C1A—C2A—H2AA109.4C1B—C2B—H2BA109.2
C1A—C2A—H2AB109.4C1B—C2B—H2BB109.2
H2AA—C2A—H2AB108.0H2BA—C2B—H2BB107.9
C3A—C2A—C1A111.3 (4)C3B—C2B—C1B112.3 (4)
C3A—C2A—H2AA109.4C3B—C2B—H2BA109.2
C3A—C2A—H2AB109.4C3B—C2B—H2BB109.2
C4A—C3A—C2A115.1 (4)C4B—C3B—C2B116.0 (4)
C5A—C3A—C2A123.7 (5)C5B—C3B—C2B123.6 (5)
C5A—C3A—C4A121.1 (5)C5B—C3B—C4B120.3 (5)
O2A—C4A—O3A123.5 (5)O2B—C4B—O3B123.7 (4)
O2A—C4A—C3A121.9 (5)O2B—C4B—C3B122.0 (5)
O3A—C4A—C3A114.5 (4)O3B—C4B—C3B114.2 (4)
C3A—C5A—H5AA120.0C3B—C5B—H5BA120.0
C3A—C5A—H5AB120.0C3B—C5B—H5BB120.0
H5AA—C5A—H5AB120.0H5BA—C5B—H5BB120.0
C7A—C6A—N1A124.1 (5)C7B—C6B—N1B119.2 (5)
C7A—C6A—C11A118.7 (5)C11B—C6B—N1B121.0 (5)
C11A—C6A—N1A117.0 (5)C11B—C6B—C7B119.8 (5)
C6A—C7A—H7A119.7C6B—C7B—H7B120.1
C8A—C7A—C6A120.5 (6)C8B—C7B—C6B119.8 (5)
C8A—C7A—H7A119.7C8B—C7B—H7B120.1
C7A—C8A—H8A119.7C7B—C8B—H8B120.1
C7A—C8A—C9A120.5 (6)C9B—C8B—C7B119.8 (5)
C9A—C8A—H8A119.7C9B—C8B—H8B120.1
C8A—C9A—Br1A120.8 (5)C8B—C9B—Br1B118.8 (4)
C8A—C9A—C10A120.5 (5)C8B—C9B—C10B120.8 (5)
C10A—C9A—Br1A118.6 (4)C10B—C9B—Br1B120.4 (4)
C9A—C10A—H10A120.6C9B—C10B—H10B120.3
C11A—C10A—C9A118.7 (5)C9B—C10B—C11B119.4 (5)
C11A—C10A—H10A120.6C11B—C10B—H10B120.3
C6A—C11A—H11A119.5C6B—C11B—C10B120.3 (5)
C10A—C11A—C6A121.1 (5)C6B—C11B—H11B119.8
C10A—C11A—H11A119.5C10B—C11B—H11B119.8
Br1A—C9A—C10A—C11A177.6 (5)Br1B—C9B—C10B—C11B179.0 (5)
O1A—C1A—C2A—C3A15.6 (6)O1B—C1B—C2B—C3B10.3 (6)
N1A—C1A—C2A—C3A166.0 (4)N1B—C1B—C2B—C3B170.7 (4)
N1A—C6A—C7A—C8A175.5 (5)N1B—C6B—C7B—C8B178.3 (5)
N1A—C6A—C11A—C10A176.3 (5)N1B—C6B—C11B—C10B178.8 (5)
C1A—N1A—C6A—C7A22.1 (8)C1B—N1B—C6B—C7B103.4 (6)
C1A—N1A—C6A—C11A163.5 (5)C1B—N1B—C6B—C11B78.4 (7)
C1A—C2A—C3A—C4A70.4 (5)C1B—C2B—C3B—C4B69.5 (5)
C1A—C2A—C3A—C5A112.3 (5)C1B—C2B—C3B—C5B113.4 (5)
C2A—C3A—C4A—O2A10.9 (7)C2B—C3B—C4B—O2B11.7 (7)
C2A—C3A—C4A—O3A167.5 (4)C2B—C3B—C4B—O3B168.0 (4)
C5A—C3A—C4A—O2A166.4 (5)C5B—C3B—C4B—O2B165.5 (5)
C5A—C3A—C4A—O3A15.1 (7)C5B—C3B—C4B—O3B14.8 (7)
C6A—N1A—C1A—O1A6.1 (8)C6B—N1B—C1B—O1B0.6 (8)
C6A—N1A—C1A—C2A172.3 (4)C6B—N1B—C1B—C2B179.6 (4)
C6A—C7A—C8A—C9A0.7 (9)C6B—C7B—C8B—C9B0.6 (8)
C7A—C6A—C11A—C10A1.6 (9)C7B—C6B—C11B—C10B0.6 (9)
C7A—C8A—C9A—Br1A178.0 (5)C7B—C8B—C9B—Br1B178.5 (4)
C7A—C8A—C9A—C10A0.6 (10)C7B—C8B—C9B—C10B0.9 (9)
C8A—C9A—C10A—C11A1.0 (9)C8B—C9B—C10B—C11B0.4 (10)
C9A—C10A—C11A—C6A1.5 (9)C9B—C10B—C11B—C6B0.3 (9)
C11A—C6A—C7A—C8A1.1 (8)C11B—C6B—C7B—C8B0.1 (8)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
O3A—H3A···O2Bi0.841.852.685 (5)174
N1A—H1A···O1Bii0.882.062.933 (5)170
O3B—H3B···O2Aiii0.841.822.654 (5)170
N1B—H1B···O1Aiv0.882.042.848 (6)152
C5B—H5BB···O1Av0.952.543.464 (7)164
Symmetry codes: (i) x, y, z1; (ii) x+1, y+1, z+1; (iii) x, y, z+1; (iv) x+2, y+2, z+1; (v) x+1, y+2, z+1.
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
O3A—H3A···O2Bi0.841.852.685 (5)173.5
N1A—H1A···O1Bii0.882.062.933 (5)169.7
O3B—H3B···O2Aiii0.841.822.654 (5)169.5
N1B—H1B···O1Aiv0.882.042.848 (6)152.4
C5B—H5BB···O1Av0.952.543.464 (7)163.5
Symmetry codes: (i) x, y, z1; (ii) x+1, y+1, z+1; (iii) x, y, z+1; (iv) x+2, y+2, z+1; (v) x+1, y+2, z+1.
 

Acknowledgements

BN thanks the UGC for financial assistance through a BSR one-time grant for the purchase of chemicals. PSN thanks Mangalore University for research facilities and DST–PURSE financial assistance. JPJ acknowledges the NSF–MRI program (grant No. CHE-1039027) for funds to purchase the X-ray diffractometer.

References

First citationAgilent (2012). CrysAlis PRO and CrysAlis RED. Agilent Technologies, Yarnton, England.  Google Scholar
First citationAllen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1–19.  CSD CrossRef Web of Science Google Scholar
First citationBan, M., Taguchi, H., Katushima, T., Takahashi, M., Shinoda, K., Watanabe, A. & Tominaga, T. (1998). Bioorg. Med. Chem. 6, 1069–1076.  Web of Science CrossRef CAS PubMed Google Scholar
First citationDolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339–341.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationGalanakis, D., Kourounakis, A. P., Tsiakitzis, K. C., Doulgkeris, C., Rekka, E. A., Gavalas, A., Kravaritou, C., Christos, C. & Kourounakis, P. N. (2004). Bioorg. Med. Chem. Lett. 14, 3639–3643.  Web of Science CrossRef PubMed CAS Google Scholar
First citationGududuru, V., Hurh, E., Dalton, J. T. & Miller, D. D. (2004). Bioorg. Med. Chem. Lett. 14, 5289–5293.  Web of Science CrossRef PubMed CAS Google Scholar
First citationKumar, P. & Knaus, E. E. (1993). Eur. J. Med. Chem. 28, 881–885.  Google Scholar
First citationLesyk, R. & Zimenkovsky, B. (2004). Curr. Org. Chem. 8, 1547–1578.  Web of Science CrossRef CAS Google Scholar
First citationNayak, P. S., Narayana, B., Jasinski, J. P., Yathirajan, H. S. & Kaur, M. (2013b). Acta Cryst. E69, o1752.  CSD CrossRef IUCr Journals Google Scholar
First citationNayak, P. S., Narayana, B., Yathirajan, H. S., Gerber, T., Brecht, B. van & Betz, R. (2013a). Acta Cryst. E69, o83.  CSD CrossRef IUCr Journals Google Scholar
First citationPalatinus, L., Prathapa, S. J. & van Smaalen, S. (2012). J. Appl. Cryst. 45, 575–580.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationUkrainets, I. V., Sidorenko, L. V., Petrushovo, L. A. & Gorokhova, O. V. (2006). Chem. Heterocycl. Comput. 42, 64–69.  CrossRef CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds